XML 28 R16.htm IDEA: XBRL DOCUMENT v3.19.3
SHARE-BASED COMPENSATION
 9 Months Ended
Sep. 29, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation SHARE-BASED COMPENSATION

Stock Options and Restricted Stock

For the thirteen week periods ended September 29, 2019 and September 30, 2018, the Company recognized $0.2 million and $0.8 million of compensation expense related to stock awards, respectively. For the thirty-nine week periods ended September 29, 2019 and September 30, 2018, the Company recognized $0.8 million and $0.9 million of compensation expense related to stock awards, respectively. Unamortized share-based compensation expense as of September 29, 2019 amounted to $2.0 million which is expected to be recognized over the next 3.0 years.
 
A summary of stock option and restricted stock activity is presented as follows:
 
Number of
Shares
 
Weighted Average Exercise Price Per Share
 
Weighted Average Remaining Contractual Life
 
Total Intrinsic Value of Awards
(in thousands)
Awards outstanding at December 30, 2018
526,985

 
$
16.49

 
7.7
 
$
2,932

Granted
138,750

 
$
21.49

 
 
 
 
Exercised
(47,790
)
 
$
10.19

 
 
 
 
Forfeited / Canceled
(34,700
)
 
$
14.39

 
 
 
 
Awards outstanding at September 29, 2019
583,245

 
$
18.32

 
7.8
 
$
2,109

 
 
 
 
 
 
 
 
Awards exercisable at December 30, 2018
238,085

 
$
13.96

 
7.2
 
$
1,684

Awards exercisable at September 29, 2019
295,045

 
$
16.37

 
7.1
 
$
1,379


 
 
Number of
Shares
 
Weighted Average Grant Date Fair Value
Nonvested outstanding at December 30, 2018
 
288,900

 
$
8.34

Nonvested outstanding at September 29, 2019
 
288,200

 
$
7.73



For the thirty-nine week period ended September 29, 2019, the Company issued 16,694 shares of common stock upon the cashless exercise of 38,614 stock options.

Included in awards outstanding are 27,000 shares of restricted stock issued in August 2018, at a grant date price per share of $28.61. For the thirteen and thirty-nine week period ended September 29, 2019, the Company recognized $0.1 million and $0.2 million of compensation expense related to restricted stock, respectively.

Warrant Activity
 
For the thirteen and thirty-nine week periods ended September 29, 2019 and September 30, 2018, the Company did not recognize compensation cost related to warrants. There was no unamortized stock compensation expense to be recognized as of September 29, 2019.
 
A summary of warrant activity is presented as follows:
 
Number of
Shares
 
Weighted Average Exercise Price Per Share
 
Weighted Average Remaining Contractual Life
 
Total Intrinsic Value of Options
(in thousands)
Warrants outstanding at December 30, 2018
93,216

 
$
11.59

 
1.3
 
$
805

Exercised
(1,020
)
 
$
14.86

 
 
 
 
Warrants outstanding at September 29, 2019
92,196

 
$
11.56

 
0.8
 
$
703

 
 
 
 
 
 
 
 
Warrants exercisable at December 30, 2018
93,216

 
$
11.59

 
1.3
 
$
805

Warrants exercisable at September 29, 2019
92,196

 
$
11.56

 
0.8
 
$
703



There were no nonvested warrants outstanding at September 29, 2019 and December 30, 2018.

For the thirty-nine week period ended September 29, 2019, the Company issued 423 shares of common stock upon the cashless exercise of 1,020 warrants.

The intrinsic value in the tables above is the amount by which the market value of the underlying stock exceeded the exercise price of outstanding options or warrants, before applicable income taxes and represents the amount holders would have realized if all in-the-money options or warrants had been exercised on the last business day of the period indicated.